X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (33) 33
humans (32) 32
oncology (20) 20
cell line, tumor (17) 17
cancer (14) 14
animals (13) 13
neuroblastoma - pathology (13) 13
tumors (11) 11
antineoplastic agents - pharmacology (10) 10
neuroblastoma (10) 10
differentiation (9) 9
histone deacetylase inhibitors (9) 9
in-vitro (9) 9
mice (9) 9
neuroblastoma - metabolism (9) 9
apoptosis (8) 8
apoptosis - drug effects (8) 8
cell proliferation - drug effects (8) 8
female (8) 8
cancer research (7) 7
cell biology (7) 7
cell survival - drug effects (7) 7
gene expression (7) 7
neoplasms (7) 7
neuroblastoma - drug therapy (7) 7
neuroblastoma - genetics (7) 7
research (7) 7
expression (6) 6
gene-expression (6) 6
histone deacetylase inhibitors - pharmacology (6) 6
medulloblastoma (6) 6
antitumor-activity (5) 5
blotting, western (5) 5
cell proliferation (5) 5
histone deacetylases - genetics (5) 5
histone deacetylases - physiology (5) 5
oncology, experimental (5) 5
phase-i (5) 5
tumor cells, cultured (5) 5
adolescent (4) 4
brain tumors (4) 4
breast-cancer (4) 4
cell cycle (4) 4
cell cycle - drug effects (4) 4
cell death (4) 4
cell differentiation - drug effects (4) 4
cells (4) 4
child (4) 4
children (4) 4
clinical neurology (4) 4
flow cytometry (4) 4
hdac (4) 4
hdac inhibitor (4) 4
hematology, oncology and palliative medicine (4) 4
histone deacetylase (4) 4
histone deacetylase inhibitor (4) 4
histone deacetylases - metabolism (4) 4
infant (4) 4
medulloblastoma - pathology (4) 4
mice, nude (4) 4
n-myc (4) 4
prognosis (4) 4
repressor proteins - genetics (4) 4
research paper (4) 4
universities and colleges (4) 4
activating mutations (3) 3
brain neoplasms - pathology (3) 3
carcinoma (3) 3
care and treatment (3) 3
cell culture (3) 3
cerebellar neoplasms - pathology (3) 3
childhood (3) 3
classification (3) 3
disease-free survival (3) 3
enzyme inhibitors - pharmacology (3) 3
ependymoma (3) 3
ependymoma - pathology (3) 3
genes, tumor suppressor (3) 3
hc-toxin (3) 3
helminthosporium-carbonum-toxin (3) 3
induction (3) 3
inhibitors (3) 3
kaplan-meier estimate (3) 3
medicine & public health (3) 3
medulloblastoma - drug therapy (3) 3
medulloblastoma - metabolism (3) 3
myc (3) 3
nervous-system (3) 3
neuroblastoma - enzymology (3) 3
neurosciences (3) 3
pathology (3) 3
pediatrics (3) 3
phenotype (3) 3
phosphorylation (3) 3
proteins (3) 3
signal transduction - drug effects (3) 3
suberoylanilide hydroxamic acid (3) 3
targeted therapy (3) 3
therapy (3) 3
transcription (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Proceedings of the National Academy of Sciences, ISSN 0027-8424, 07/2013, Volume 110, Issue 28, pp. E2592 - E2601
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 2, pp. 2304 - 2319
Fewer than 50% of patients with high-risk neuroblastoma survive five years after diagnosis with current treatment protocols. Molecular targeted therapies are... 
CDKN1A | Pediatric tumors | MYCN | Targeted therapy | Apoptosis
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 12/2012, Volume 110, Issue 3, pp. 335 - 348
Journal Article
International journal of cancer, ISSN 0020-7136, 07/2019
Accurate modeling of intratumor heterogeneity presents a bottleneck against drug testing. Flexibility in a preclinical platform is also desirable to support... 
Index Medicus
Journal Article
Cancer Cell, ISSN 1535-6108, 08/2016, Volume 30, Issue 2, pp. 357 - 358
(Cancer Cell 24, 75–89; July 8, 2013) In the original Figure 7C, the authors mistakenly used the same control histology panel twice: the top left and bottom... 
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 11/2011, Volume 122, Issue 5, pp. 637 - 650
Incompletely resectable ependymomas are associated with poor prognosis despite intensive radio- and chemotherapy. Novel treatments have been difficult to... 
Pathology | Neurosciences | Histone deacetylase inhibitor | Medicine & Public Health | Cancer stem cells | Differentiation | Ependymoma | ABNORMALITIES | TUMOR | PATHOLOGY | IDENTIFICATION | CHILDHOOD | NEUROSCIENCES | CLINICAL NEUROLOGY | CHILDREN | GROWTH-FACTOR RECEPTOR | PLASMA | INTRACRANIAL EPENDYMOMAS | PHASE-I | EXPRESSION | Supratentorial Neoplasms - pathology | Humans | Histone Deacetylase Inhibitors - administration & dosage | Injections, Intraventricular | Neural Stem Cells - drug effects | Transplantation, Heterologous | Gene Expression Profiling | Neural Stem Cells - pathology | Phenotype | Animals | Cell Differentiation - drug effects | Models, Biological | Cell Line, Tumor | Hydroxamic Acids - administration & dosage | Ependymoma - pathology | Histone Deacetylase Inhibitors - pharmacology | Mice | In Vitro Techniques | Hydroxamic Acids - pharmacology | Chemotherapy | Molecular genetics | Neurons | Oncology, Experimental | Brain tumors | Stem cells | Transplantation | Research | Universities and colleges | Metastasis | Biometry | Cancer | Index Medicus | temozolomide | Cell culture | Histone deacetylase | Prognosis | Risk groups | Gene expression | Vincristine | Cisplatin | Metastases | Plasticity (neural) | Molecular modelling | Xenografts | Tumors | ependymoma | differentiation | cancer stem cells | histone deacetylase inhibitor
Journal Article